General Information of the Compound
Compound ID
CP0538669
Compound Name
3-[4-(3-naphthalen-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]propan-1-ol
    Show/Hide
Structure
Formula
C20H23N3O2
Molecular Weight
337.423
Canonical SMILES
OCCCN1CCC(CC1)c1nc(no1)-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C20H23N3O2/c24-13-3-10-23-11-8-16(9-12-23)20-21-19(22-25-20)18-7-6-15-4-1-2-5-17(15)14-18/h1-2,4-7,14,16,24H,3,8-13H2
    Show/Hide
InChIKey
DGKNPCPCJDLWQR-UHFFFAOYSA-N
Physicochemical Property
logP
3.4516
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
62.39
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 150026820
ChEMBL ID
CHEMBL4564891
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 40400 nM
   TI
   LI
   LO
   TS